心脏移植术后多模态影像学评估研究进展  

Research progresses of multimodality imaging assessment after heart transplantation

作　　者：谢雨霁 孙薇 朱双双 张易薇 吴纯 方凌云 张丽 XIE Yuji;SUN Wei;ZHU Shuangshuang;ZHANG Yiwei;WU Chun;FANG Lingyun;ZHANG Li(Department of Ultrasound Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Hubei Province Clinical Research Center for Medical Imaging,Wuhan 430022,China;Hubei Province Key Laboratory of Molecular Imaging,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院超声医学科,湖北武汉430022 [2]湖北省影像医学临床医学研究中心,湖北武汉430022 [3]分子影像湖北省重点实验室,湖北武汉430022

出　　处：《中国医学影像技术》2023年第9期1402-1406,共5页Chinese Journal of Medical Imaging Technology

基　　金：国家自然科学基金(82151316);湖北省自然科学基金(2021CFA046)。

摘　　要：心脏移植是治疗终末期心力衰竭的有效方法。术后早期急性细胞排斥反应(ACR)和中远期心脏移植物血管病变(CAV)是影响患者总生存率的主要因素。多模态影像学可准确、及时评估移植心脏结构和功能,对早期诊断及管理术后并发症具有重要意义。本文就心脏移植术后多模态影像学评估研究进展进行综述。Heart transplantation is an effective method for treating end-stage heart failure.Early acute cellular rejection(ACR)and mid-and long-term cardiac allograft vasculopathy(CAV)are the main impact factors of patients overall survival rate.Multimodality imaging could be used to timely and accurately evaluate the structure and function of the transplanted heart,having great significance for early diagnosis and management of postoperative complications.The research progresses of multimodality imaging assessment after heart transplantation were reviewed in this article.

关 键 词：心脏移植 移植物排斥 诊断显像 

分 类 号：R392.4[医药卫生—免疫学] R445[医药卫生—基础医学]